Polymer compound comprising pendent peptides, method for preparing same and uses thereof
US-2024084068-A1 · Mar 14, 2024 · US
Gadd45beta targeting agents
US9518083B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9518083-B2 |
| Application number | US-201514618613-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 10, 2015 |
| Priority date | Oct 22, 2009 |
| Publication date | Dec 13, 2016 |
| Grant date | Dec 13, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound according to Formula I or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
Assignees
Inventors
Classifications
with the first amino acid being acidic · CPC title
and aromatic or cycloaliphatic · CPC title
Asp- or Asn-amino acid · CPC title
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
and aromatic or cycloaliphatic · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9518083B2 cover?
- Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
- Who is the assignee on this patent?
- Imp Innovations Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07K5/06078. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).